Characteristics and mortality of patients with rheumatologic diseases admitted at an intensive care unit of Paraguay
Abstract
Introduction: Rheumatologic diseases are not unusual in general population. This group of patients usually requires hospitalization for various causes and up to a third of them may be admitted to the Intensive Care Unit (ICU). The prognosis can be unfavorable, especially in the presence of renal involvement. Objective: To characterize rheumatologic patients admitted to Intensive Care and determi- ne their mortality. Methods: We conducted a descriptive, retrospective cross-sectional study. Data were collec- ted from medical records of patients with rheumatic diseases admitted to the ICU of the Hospital de Clínicas from January 2021 to December 2022. Results: Twenty-nine patients with rheumatic diseases were admitted in the two years of the study. Twenty-three (79.31%) were women. The median age was 37 years (IQR 22.5). Twenty patients (68.9%) had Systemic Lupus Erythematosus, five (17.2%) rheumatoid arthri- tis and there maining four patients (3.44%) had mixed connective tissue disease, Sjogren‘s Syndrome, Overlap Syndrome and Churg Strauss Vasculitis. The most frequent comorbidi- ties were: arterial hypertension (55%) and nephropathy (41.3%). The causes of admission to the ICU were medical (62%) and surgical (38%). Between medical causes, respiratory failure was the main reason (44%), followed by shock (27%) and intercurrent infections (11.1%). The mean APACHE II (Assessment of Age and Chronic Health) score was 17 ± 10; SOFA on admission (Sequential Organ Failure Assessment): 6 ± 8.5 and the SLEDAI Scale (Systemic Lupus Erythematosus Disease Activity Measure) in lupus patients: 10.6 ± 8.3. Nineteen patients (65.5%) received mechanical ventilation (MV) with a median number of days on MV of 6 (IQR 9). Vasoactive drugs were used by 65.5% and hemodialysis by 17.2%. Methylprednisolone was administered to 10 of the patients (37.9%), in addition 4 of them required cyclophosphamide and 3 immunoglobulins. During hospitalization thirteen patients (44.8%) developed acute renal failure and twelve of them (41.3%) intercurrent in- fections; 6 of them with blood stream Gram Positive isolation. The median length of stay in the ICU was 6 days (IQR: 10) and mortality was 37.9% (eleven patients). Conclusions: In our study, the population was mainly young women with several comorbi- dities, who were admitted in serious condition to the ICU, most of them for medical reasons. Two-thirds required MV and vasoactive drugs. They presented complications such as acute renal failure and intercurrent infections. Mortality was 38%, only a little higher than that corres- ponding to the gravity score of income.
Downloads
References
(1) Ranzani OT, Battaini LC, Moraes CE, Prada LF, Pinaffi JV, Giannini FP, Shinjo SK, Azevedo LC,et al. Outcomes and organ dysfunctions of critically ill patients with systemic lupus erythemato- sus and other systemic rheumatic diseases. Braz J Med Biol Res. 2011 Nov;44(11):1184-93. doi: 10.1590/s0100-879x2011007500132. Epub 2011 Oct 13. PMID: 22002091.
(2) Arjmand M, Shahriarirad R, Shenavandeh S, Fallahi MJ. Determination of the main causes, outcome, and prognostic factors of patients with rheumatologic diseases admitted to the medical intensive care unit in Southern Iran. Clin Rheumatol. 2022 Dec;41(12):3859-3868. doi: 10.1007/s10067-022-06334-5. Epub 2022 Aug 15. PMID: 35969279; PMCID: PMC9376566.
(3) Camargo JF, Tobón GJ, Fonseca N, Diaz JL, Uribe M, Molina F, et al. Autoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature. Lupus. 2005;14(4):315-20. doi: 10.1191/0961203305lu- 2082oa. PMID: 15864918.
(4) Aragón CC, Ruiz-Ordoñez I, Quintana JH, Suárez-Avellaneda A, Gallego LM, Gallego CN, et al. Clinical characterization, outcomes, and prognosis in patients with systemic lupus erythe- matosus admitted to the intensive care unit. Lupus. 2020 Aug;29(9):1133-1139. doi: 10.1177/0961203320935176. Epub 2020 Jun 30. PMID: 32605526.
(5) Brünnler T, Susewind M, Hoffmann U, Rockmann F, Ehrenstein B, Fleck M. Outcomes and Prognostic Factors in Patients with Rheu- matologic Diseases Admitted to the ICU. Intern Med. 2015;54(16):1981-7. doi: 10.2169/internalmedicine.54.4283. Epub 2015 Aug 15. PMID: 26278288.
(6) Fontclara L, Bianco H. Factores de riesgo de mortalidad en pacientes con lupus eritematoso sistémico en una unidad de cuidados intensivos. Rev. Parag. Reumatol.2015;1(2):85-93.
(7) Carrizosa JA, Aponte J, Cartagena D, Cervera R, Ospina MT, Sanchez A. Factores asociados a la mortalidad en pacientes con enfermedades autoinmunes ingresados en la unidad de cuidados intensivos de Bogotá, Colombia. Front. Inmunol. 2017; 8: 1–6. https://doi.org/10.3389/fimmu.2017.00337
(8) Shi Y, Du B, Zhao JL, Qin HY, Hu XY, Jiang W, et al. Etiologies and outcomes of rheumatology patients with acute respiratory failure requiring intensive care: a single-center medical records review study of 259 patients. Clin Rheumatol. 2020 Nov;39(11):3479- 3488. doi: 10.1007/s10067-020-05080-w. Epub 2020 May 6. PMID: 32372293.
(9) Dumas G, Géri G, Montlahuc C, Chemam S, Dangers L, Pichereau et al. Outcomes in critically ill patients with systemic rheumatic disease: a multicenter study. Chest. 2015 Oct;148(4):927-935. doi: 10.1378/chest.14-3098. PMID: 25996557.
(10) Richter A, Listing J, Schneider M, Klopsch T, Kapelle A, Kaufmann J, et al. Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumato id arthritis. Ann Rheum Dis. 2016 Sep;75(9):1667-73. doi: 10.1136/ annrheumdis-2015-207838. Epub 2015 Nov 13. PMID: 26567181; PMCID: PMC5013078.
(11) Fujiwara T, Tokuda K, Momii K, Shiomoto K, Tsushima H, Akasaki Y, et al. Prognostic factors for the short-term mortality of patients with rheumatoid arthritis admitted to intensive care units. BMC Rheumatol. 2020 Dec 4;4(1):64. doi: 10.1186/s41927-020- 00164-1. PMID: 33292831; PMCID: PMC7716508.
(12) Janssen NM, Karnad DR, Guntupalli KK. Rheumatologic diseases in the intensive care unit: epidemiology, clinical approach, management, and outcome. Crit Care Clin. 2002 Oct;18(4):729-48. doi: 10.1016/s0749-0704(02)00025-8. PMID: 12418438.
(13) Beil M, Sviri S, de la Guardia V, Stav I, Ben-Chetrit E, van Heerden PV. Prognosis of patients with rheumatic diseases admitted to intensive care. Anaesth Intensive Care. 2017 Jan;45(1):67-72. doi: 10.1177/0310057X1704500110. PMID: 28072937.
(14) Avouac J, Amrouche F, Meune C, Rey G, Kahan A, Allanore Y. Mortality profile of patients with rheumatoid arthritis in France and its change in 10 years. Semin Arthritis Rheum. 2017 Apr;46(5):537- 543. doi: 10.1016/j.semarthrit.2016.10.007. Epub 2016 Oct 29. PMID: 27908535.
(15) Larcher R, Pineton de Chambrun M, Garnier F, Rubenstein E, Carr J, Charbit J, et al. One-Year Outcome of Critically Ill Patients With Systemic Rheumatic Disease: A Multicenter Cohort Study. Chest. 2020 Sep;158(3):1017-1026. doi: 10.1016/j.chest.2020.03.050. Epub 2020 Apr 11. PMID: 32289313.
(16) Antón JM, Castro P, Espinosa G, Marcos M, Gandía M, Merchán R, et al. Mortality and long term survival prognostic factors of patients with systemic autoimmune diseases admitted to an intensive care unit: a retrospective study. Clin Exp Rheumatol. 2012 May-Jun;30(3):338-44. Epub 2012 Jun 25. PMID: 22338619.
(17) Faguer S, Ciroldi M, Mariotte E, Galicier L, Rybojad M, Canet E, et al. Prognostic contributions of the underlying inflammatory disease and acute organ dysfunction in critically ill patients with systemic rheumatic diseases. Eur J Intern Med. 2013 Apr;24(3):e40-4. doi: 10.1016/j.ejim.2012.11.018. Epub 2013 Jan 16. PMID: 23332934.
(18) Barrett O, Abramovich E, Dreiher J, Novack V, Abu-Shakra M. Short- and long-term mortality due to sepsis in patients with rheumatoid arthritis. Rheumatol Int. 2017 Jun;37(6):1021-1026. doi: 10.1007/ s00296-017-3694-5. Epub 2017 Mar 12. PMID: 28286904.
(19) Chabert P, Danjou W, Mezidi M, Berthiller J, Bestion A, Fred AA, et al. Short- and long-term prognosis of acute critically ill patients with systemic rheumatic diseases: A retrospective multicentre study. Medicine (Baltimore). 2021 Sep 3;100(35):e26164. doi: 10.1097/ MD.0000000000026164. PMID: 34477112; PMCID: PMC8415942.
(20) Lee J, Yim JJ, Yang SC, Yoo CG, Kim YW, Han SK, et al. Outcome of patients with connective tissue disease requiring intensive care for respiratory failure. Rheumatol Int. 2012 Nov;32(11):3353-8. doi: 10.1007/s00296-011-2158-6. Epub 2011 Sep 27. PMID: 21947378.
(21) Godeau B, Mortier E, Roy PM, Chevret S, Bouachour G, Schlemmer B, et al. Short and longterm outcomes for patients with systemic rheumatic diseases admitted to intensive care units: a prognostic study of 181 patients. J Rheumatol. 1997 Jul;24(7):1317-23. PMID: 9228131.
(22) Mustafa M, Gladston Chelliah E, Hughes M. Patients with systemic rheumatic diseases admitted to the intensive care unit: what the rheumatologist needs to know. Rheumatol Int. 2018 Jul;38(7):1163- 1168. doi: 10.1007/s00296-018-4008-2. Epub 2018 Mar 16. PMID: 29549383.
(23) Keyßer G. Epidemiologie und Outcome von Rheumapatienten auf der Intensivstation [Epidemiology and outcome of patients with rheumatic diseases in the intensive care unit]. Z Rheumatol. 2019 Dec;78 (10):925-931. German. doi: 10.1007/s00393-019-00693-2. PMID:
Copyright (c) 2023 Jessica Figueredo, Iris Colmán, Federico Fretes, Marcelo Pederzani, Lorena Fontclara, Ricardo Caballero, Patricia Añazco, Hugo Bianco, Belinda Figueredo

This work is licensed under a Creative Commons Attribution 4.0 International License.